Publications
- Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex2021 | Second Faculty of Medicine, Central Library of Charles University
- Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma2017 | First Faculty of Medicine, Second Faculty of Medicine
- Variation in genomic landscape of clear cell renal cell carcinoma across Europe2014 | First Faculty of Medicine, Second Faculty of Medicine
- Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States2013 | First Faculty of Medicine, Second Faculty of Medicine
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study2024 | Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Transurethral resection of bladder cancer with or without fluorescence2023 | Second Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...